Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

ICS-formoterol reliever therapy stepwise treatment algorithm for adult asthma.

Beasley R, Braithwaite I, Semprini A, Kearns C, Weatherall M, Harrison TW, Papi A, Pavord ID.

Eur Respir J. 2020 Jan 9;55(1). pii: 1901407. doi: 10.1183/13993003.01407-2019. Print 2020 Jan. No abstract available.

PMID:
31919194
2.

Is it time to move away from short-acting beta-agonists in asthma management?

Martin MJ, Harrison TW.

Eur Respir J. 2019 Apr 4;53(4). pii: 1802223. doi: 10.1183/13993003.02223-2018. Print 2019 Apr. No abstract available.

PMID:
30948504
3.

Idiopathic chronic productive cough and response to open-label macrolide therapy: An observational study.

Martin MJ, Lee H, Clayton C, Pointon K, Soomro I, Shaw DE, Harrison TW.

Respirology. 2019 Jun;24(6):558-565. doi: 10.1111/resp.13483. Epub 2019 Feb 5.

4.

Can a temporary increase in corticosteroid dosage reduce asthma exacerbations?

Sutherland LG, Harrison TW.

Expert Rev Respir Med. 2018 Dec;12(12):993-995. doi: 10.1080/17476348.2018.1547636. Epub 2018 Nov 27. No abstract available.

PMID:
30415575
5.

Quintupling inhaled fluticasone at first sign of exacerbation.

Harrison TW.

J Pediatr. 2018 Sep;200:291-294. doi: 10.1016/j.jpeds.2018.07.014. No abstract available.

PMID:
30144926
6.

Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD.

Janson C, Stratelis G, Miller-Larsson A, Harrison TW, Larsson K.

Int J Chron Obstruct Pulmon Dis. 2017 Oct 19;12:3055-3064. doi: 10.2147/COPD.S143656. eCollection 2017. Review.

7.

Autoantibodies of IgM and IgG classes show differences in recognition of multiple autoantigens in chronic obstructive pulmonary disease.

Shindi R, Almehairi A, Negm OH, Kalsheker N, Gale NS, Shale DJ, Harrison TW, Bolton CE, John M, Todd I, Tighe PJ, Fairclough LC.

Clin Immunol. 2017 Oct;183:344-353. doi: 10.1016/j.clim.2017.09.020. Epub 2017 Sep 23.

PMID:
28951328
8.

Matrix Metalloproteinase-1 Activation Contributes to Airway Smooth Muscle Growth and Asthma Severity.

Naveed SU, Clements D, Jackson DJ, Philp C, Billington CK, Soomro I, Reynolds C, Harrison TW, Johnston SL, Shaw DE, Johnson SR.

Am J Respir Crit Care Med. 2017 Apr 15;195(8):1000-1009. doi: 10.1164/rccm.201604-0822OC.

9.

Evaluation of the PPAR-γ Agonist Pioglitazone in Mild Asthma: A Double-Blind Randomized Controlled Trial.

Anderson JR, Mortimer K, Pang L, Smith KM, Bailey H, Hodgson DB, Shaw DE, Knox AJ, Harrison TW.

PLoS One. 2016 Aug 25;11(8):e0160257. doi: 10.1371/journal.pone.0160257. eCollection 2016.

10.

Assessment of a rapid liquid-based cytology method for measuring sputum cell counts.

Martin MJ, Lee H, Meakin G, Green A, Simms RL, Reynolds C, Winters S, Shaw DE, Soomro I, Harrison TW.

Thorax. 2016 Dec;71(12):1163-1164. doi: 10.1136/thoraxjnl-2016-208817. Epub 2016 Aug 8.

PMID:
27503234
11.

The utility of exhaled nitric oxide in patients with suspected asthma.

Martin MJ, Wilson E, Gerrard-Tarpey W, Meakin G, Hearson G, McKeever TM, Shaw DE, Harrison TW.

Thorax. 2016 Jun;71(6):562-4. doi: 10.1136/thoraxjnl-2015-208014. Epub 2016 Feb 22.

PMID:
26903595
12.

Using venous blood gas analysis in the assessment of COPD exacerbations: a prospective cohort study.

McKeever TM, Hearson G, Housley G, Reynolds C, Kinnear W, Harrison TW, Kelly AM, Shaw DE.

Thorax. 2016 Mar;71(3):210-5. doi: 10.1136/thoraxjnl-2015-207573. Epub 2015 Dec 1.

13.

Causes of chronic productive cough: An approach to management.

Martin MJ, Harrison TW.

Respir Med. 2015 Sep;109(9):1105-13. doi: 10.1016/j.rmed.2015.05.020. Epub 2015 Jul 6. Review.

14.

Cardiovascular and inflammatory effects of simvastatin therapy in patients with COPD: a randomized controlled trial.

John ME, Cockcroft JR, McKeever TM, Coward WR, Shale DJ, Johnson SR, Thornton JG, Harrison TW, Knox AJ, Bolton CE.

Int J Chron Obstruct Pulmon Dis. 2015 Jan 29;10:211-21. doi: 10.2147/COPD.S76061. eCollection 2015.

15.

Development and validation of a novel risk score for asthma exacerbations: The risk score for exacerbations.

Bateman ED, Buhl R, O'Byrne PM, Humbert M, Reddel HK, Sears MR, Jenkins C, Harrison TW, Quirce S, Peterson S, Eriksson G.

J Allergy Clin Immunol. 2015 Jun;135(6):1457-64.e4. doi: 10.1016/j.jaci.2014.08.015. Epub 2014 Sep 23.

PMID:
25258144
16.

Extra-cellular matrix proteins induce matrix metalloproteinase-1 (MMP-1) activity and increase airway smooth muscle contraction in asthma.

Rogers NK, Clements D, Dongre A, Harrison TW, Shaw D, Johnson SR.

PLoS One. 2014 Feb 28;9(2):e90565. doi: 10.1371/journal.pone.0090565. eCollection 2014.

17.

Inhaled corticosteroids and the risk of pneumonia in people with asthma: a case-control study.

McKeever T, Harrison TW, Hubbard R, Shaw D.

Chest. 2013 Dec;144(6):1788-1794. doi: 10.1378/chest.13-0871.

PMID:
23990003
18.

Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps.

Bateman ED, Harrison TW, Quirce S, Reddel HK, Buhl R, Humbert M, Jenkins CR, Peterson S, Ostlund O, O'Byrne PM, Sears MR, Eriksson GS.

Respir Res. 2011 Apr 4;12:38. doi: 10.1186/1465-9921-12-38.

19.

Overall asthma control: the relationship between current control and future risk.

Bateman ED, Reddel HK, Eriksson G, Peterson S, Ostlund O, Sears MR, Jenkins C, Humbert M, Buhl R, Harrison TW, Quirce S, O'Byrne PM.

J Allergy Clin Immunol. 2010 Mar;125(3):600-8, 608.e1-608.e6. doi: 10.1016/j.jaci.2009.11.033. Epub 2010 Feb 11.

PMID:
20153029
20.

Measuring asthma control: a comparison of three classification systems.

O'Byrne PM, Reddel HK, Eriksson G, Ostlund O, Peterson S, Sears MR, Jenkins C, Humbert M, Buhl R, Harrison TW, Quirce S, Bateman ED.

Eur Respir J. 2010 Aug;36(2):269-76. doi: 10.1183/09031936.00124009. Epub 2010 Jan 28.

21.
22.

Quadrupling the dose of inhaled corticosteroid to prevent asthma exacerbations: a randomized, double-blind, placebo-controlled, parallel-group clinical trial.

Oborne J, Mortimer K, Hubbard RB, Tattersfield AE, Harrison TW.

Am J Respir Crit Care Med. 2009 Oct 1;180(7):598-602. doi: 10.1164/rccm.200904-0616OC. Epub 2009 Jul 9.

PMID:
19590019
23.

Systemic and bronchodilator effects of inhaled rac-formoterol in subjects with chronic obstructive pulmonary disease: a dose-response study.

Whale CI, Sovani MP, Mortimer KJ, Harrison TW, Tattersfield AE.

Br J Clin Pharmacol. 2008 Jun;65(6):841-7. doi: 10.1111/j.1365-2125.2007.03081.x. Epub 2008 Apr 3.

24.

Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help?

Sovani MP, Whale CI, Oborne J, Cooper S, Mortimer K, Ekström T, Tattersfield AE, Harrison TW.

Br J Gen Pract. 2008 Jan;58(546):37-43. doi: 10.3399/bjgp08X263802.

25.

Plasma concentrations of fluticasone propionate and budesonide following inhalation: effect of induced bronchoconstriction.

Mortimer KJ, Tattersfield AE, Tang Y, Wu K, Lewis S, Hochhaus G, Harrison TW.

Br J Clin Pharmacol. 2007 Oct;64(4):439-44. Epub 2007 Aug 15.

26.

Plasma concentrations of inhaled corticosteroids in relation to airflow obstruction in asthma.

Mortimer KJ, Harrison TW, Tang Y, Wu K, Lewis S, Sahasranaman S, Hochhaus G, Tattersfield AE.

Br J Clin Pharmacol. 2006 Oct;62(4):412-9.

27.

Effects of rac-albuterol on arterial blood gases in patients with stable hypercapnic chronic obstructive pulmonary disease.

Whale CI, Sovani MP, Mortimer K, Oborne J, Cooper S, Harrison TW, Tattersfield AE.

Br J Clin Pharmacol. 2006 Aug;62(2):153-7.

28.

Oral and inhaled corticosteroids and adrenal insufficiency: a case-control study.

Mortimer KJ, Tata LJ, Smith CJ, West J, Harrison TW, Tattersfield AE, Hubbard RB.

Thorax. 2006 May;61(5):405-8. Epub 2006 Mar 3.

29.

beta-Adrenoceptor polymorphisms: focus moves to long-acting beta-agonists.

Tattersfield AE, Harrison TW.

Am J Respir Crit Care Med. 2006 Mar 1;173(5):473-4. No abstract available.

PMID:
16493161
30.

Safety of inhaled corticosteroids.

Tattersfield AE, Harrison TW, Hubbard RB, Mortimer K.

Proc Am Thorac Soc. 2004;1(3):171-5. Review.

PMID:
16113431
31.

Effects of inhaled corticosteroids on bone.

Mortimer KJ, Harrison TW, Tattersfield AE.

Ann Allergy Asthma Immunol. 2005 Jan;94(1):15-21; quiz 22-3, 79. Review.

PMID:
15702810
32.

Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial.

Harrison TW, Oborne J, Newton S, Tattersfield AE.

Lancet. 2004 Jan 24;363(9405):271-5.

PMID:
14751699
33.

Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide.

Phillips K, Oborne J, Lewis S, Harrison TW, Tattersfield AE.

Thorax. 2004 Jan;59(1):26-30.

34.

Use of sequential quadrupling dose regimens to study efficacy of inhaled corticosteroids in asthma.

Phillips K, Oborne J, Harrison TW, Tattersfield AE.

Thorax. 2004 Jan;59(1):21-5.

35.

Radiologic emergency: protecting schoolchildren and the public.

Harrison TW, Gustafson EM, Dixon JK.

Am J Nurs. 2003 May;103(5):41-9; quiz 50. Review. No abstract available.

PMID:
12759602
36.

Adolescent homosexuality and concerns regarding disclosure.

Harrison TW.

J Sch Health. 2003 Mar;73(3):107-12. Review.

PMID:
12677729
37.

Low-dose budesonide for asthma.

Tattersfield AE, Harrison TW.

Lancet. 2003 Mar 29;361(9363):1066-7. No abstract available. Erratum in: Lancet. 2003 Jun 7;361(9373):1994.

PMID:
12672304
38.

Systemic effects of inhaled corticosteroids.

Harrison TW, Tattersfield AE.

Am J Respir Crit Care Med. 2003 Apr 1;167(7):1037-8; author reply 1038. No abstract available.

PMID:
12663345
40.

West Nile encephalitis.

Harrison TW.

J Pediatr Health Care. 2002 Nov-Dec;16(6):278-81. Review.

PMID:
12436096
41.

Inhaled corticosteroids and hip fracture: a population-based case-control study.

Hubbard RB, Smith CJ, Smeeth L, Harrison TW, Tattersfield AE.

Am J Respir Crit Care Med. 2002 Dec 15;166(12 Pt 1):1563-6. Epub 2002 Sep 25.

PMID:
12406825
42.

Exacerbations of asthma--still room for improvement.

Tattersfield AE, Harrison TW.

Lancet. 2001 Aug 25;358(9282):599-601. No abstract available.

PMID:
11530142
44.

Inhaled steroids for COPD?

Tattersfield AE, Harrison TW.

Thorax. 2001 Sep;56 Suppl 2:ii2-6. Review. No abstract available.

45.
46.

New drugs in asthma.

Phillips K, Harrison TW, Tattersfield A.

J R Coll Physicians Lond. 1999 Sep-Oct;33(5):425-30. Review. No abstract available.

PMID:
10624655
47.

Step 3 of the asthma guidelines.

Tattersfield AE, Harrison TW.

Thorax. 1999 Sep;54(9):753-4. No abstract available.

48.

Randomised placebo controlled trial of beta agonist dose reduction in asthma.

Harrison TW, Oborne J, Wilding PJ, Tattersfield AE.

Thorax. 1999 Feb;54(2):98-102.

49.

Effect of single doses of inhaled lignocaine on FEV1 and bronchial reactivity in asthma.

Harrison TW, Tattersfield AE.

Respir Med. 1998 Dec;92(12):1359-63.

50.

The contribution of the swallowed fraction of an inhaled dose of salmeterol to it systemic effects.

Bennett JA, Harrison TW, Tattersfield AE.

Eur Respir J. 1999 Feb;13(2):445-8.

Supplemental Content

Loading ...
Support Center